Sign in

CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464348039
Phone
617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +31,028 $28.82 $894K 539,774
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +29,244 $29.42 $860K 569,018
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +2,654 $31.00 $82K 571,672
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +4,125 $31.86 $131K 575,797
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +3,866 $32.47 $126K 579,663
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +18,055 $33.71 $609K 597,718
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +31,549 $34.62 $1.1M 629,267
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +32,295 $35.83 $1.2M 661,562
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +16,484 $36.53 $602K 678,046
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +43,754 $37.49 $1.6M 721,800
2024-01-26 Cormorant Asset Management, LP 10% owner Purchase +3,200 $38.49 $123K 725,000
2023-05-18 Altmeyer Anne Director Grant or award · Stock Option (right to buy) +5,300 5,300
2023-05-18 Jenkins John Kenneth Director Grant or award · Stock Option (right to buy) +5,300 5,300
2023-05-18 Jacques Rachelle Suzanne Director Grant or award · Stock Option (right to buy) +5,300 5,300
2023-05-18 Salzmann Peter Director Grant or award · Stock Option (right to buy) +5,300 5,300
2023-05-18 HOLMER ALAN F Director Grant or award · Stock Option (right to buy) +5,300 5,300
2023-05-18 Ben Yong Director Grant or award · Stock Option (right to buy) +5,300 5,300
2023-05-18 CATLIN AVERY W Director Grant or award · Stock Option (right to buy) +5,300 5,300
2023-03-06 Ben Yong Director Grant or award · Stock Option(right to buy) +5,307 5,307
2023-02-13 Brake Rachael Louise Chief Scientific Officer Grant or award · Stock Option (right to buy) +1,400,000 1,400,000

Page 9 of 10 · 200 trades